Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients DOI Creative Commons
Hersh D. Ravkin, Lior Nesher

Infectious Diseases and Therapy, Journal Year: 2024, Volume and Issue: 13(11), P. 2223 - 2225

Published: Oct. 10, 2024

Language: Английский

Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis DOI Creative Commons
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino

et al.

European journal of medical research, Journal Year: 2024, Volume and Issue: 29(1)

Published: Oct. 4, 2024

Language: Английский

Citations

5
New approach methodologies to assess wanted and unwanted drugs-induced immunostimulation DOI Creative Commons
Valeria Bettinsoli, Gloria Melzi,

I. Marchese

et al.

Current Research in Toxicology, Journal Year: 2025, Volume and Issue: 8, P. 100222 - 100222

Published: Jan. 1, 2025

This review examines various classes of drugs, focusing on their therapeutic and adverse effects, particularly in relation to immunostimulation. We emphasize the potential new approach methodologies (NAMs) study both expected unexpected immunostimulatory effects. By evaluating modes action different we aim provide insights into effectively assessing unwanted responses. The begins by exploring drugs that stimulate immune system-including immunostimulants, monoclonal antibodies, chemotherapeutics, nucleic acid-based drugs-to outline NAMs could be employed evaluate

Language: Английский

Citations

0
COVID-19 convalescent plasma in immunocompromised COVID-19 patients: more certainty and clarity are added to a complex evidence base DOI
Hyunah Yoon, Liise-anne Pirofski

EBioMedicine, Journal Year: 2025, Volume and Issue: 114, P. 105654 - 105654

Published: March 18, 2025

Language: Английский

Citations

0
Interferon-α Nasal Spray to Prevent COVID-19 and Respiratory Viral Infections in Cancer Patients; a Randomised, Double-Blinded Placebo-Controlled Trial DOI
Michelle K. Yong, Karin Thursky, Megan Crane

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0
Fresh frozen plasma for neutralizing SARS-CoV-2: “An exploratory cross-sectional study and review of the state of the art” DOI

Marcial Delgado‐Fernández,

Juan Diego Ruíz-Mesa,

Almudena Rojas-González

et al.

Enfermedades Infecciosas y Microbiología Clínica, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Citations

0
Fresh frozen plasma for neutralizing SARS-CoV-2: “An exploratory cross-sectional study and review of the state of the art” DOI

Marcial Delgado‐Fernández,

Juan Diego Ruíz-Mesa,

Almudena Rojas-González

et al.

Enfermedades infecciosas y microbiologia clinica (English ed ), Journal Year: 2025, Volume and Issue: 43(5), P. 282 - 290

Published: May 1, 2025

Language: Английский

Citations

0
Author Response to: “COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-cell Recipients: Correspondence” DOI

Emily A. Rosen,

Catherine Liu

Transplantation and Cellular Therapy, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 1, 2024

Language: Английский

Citations

2
Vaccines for Use in Special Populations: Immunocompromised Hosts DOI Creative Commons
Michael G. Ison

The Journal of Infectious Diseases, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 15, 2024

Language: Английский

Citations

1
Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients DOI Creative Commons
Hersh D. Ravkin, Lior Nesher

Infectious Diseases and Therapy, Journal Year: 2024, Volume and Issue: 13(11), P. 2223 - 2225

Published: Oct. 10, 2024

Language: Английский

Citations

0